Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to January 2026, from the company's annual filing with the SEC.
| Salesyearly sales | $1.7B |
| Sales growthchange from the year before | +9.2% |
| Operating marginshare of sales left after running the business | 7.4% |
| Net marginshare of sales kept as profit | 1.3% |
| Free-cash-flow marginspare cash generated per $100 of sales | 2.9% |
| Return on invested capitalprofit made on each $100 put into the business | 8.4% |
| Return on equityprofit vs. shareholders' accounting value | 5.2% |
| Debt / equitydebt vs. shareholders' accounting value | 1.68 |
| Change in share countnegative = the company is buying back its shares | -2.4% |
2 insiders sold $262K (all under pre-arranged plans) on the open market.
| Geisser Melinda L.Chief People Services Officer | Sold (plan)Aug 3 | 14,059 shat $10.48 · $147K |
| Medway Richard A.General Counsel | Sold (plan)Aug 3 | 10,000 shat $10.48 · $105K |
| Geisser Melinda L.Chief People Services Officer | Sold (plan)Jul 31 | 941 shat $10.48 · $10K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy